- Cytoreductive prostatectomy may improve oncological outcomes in patients with oligometastatic prostate cancer: An updated systematic review and meta-analysis
-
Chung DY, Kang DH, Jung HD, Lee JY, Kim DK, Ha JS, Jeon J, Cho KS
- KMID: 2542247
- Investig Clin Urol.
- 2023 May;64(3):242-254.
- doi: 10.4111/icu.20230058
The oncologic outcomes of cytoreductive prostatectomy (CRP) in oligometastatic prostate cancer (OmPCa) are still controversial. Therefore, we conducted a systematic review and meta-analysis on the oncologic outcome of CRP in... -
- CITED
-
- Close
- SHARE
-
- Close
- Proper Oral Hygiene and Dental Care for Cancer Patients
-
Nam SJ
- KMID: 2541627
- J Dig Cancer Res.
- 2023 Apr;11(1):41-44.
- doi: 10.52927/jdcr.2023.11.1.41
Oral complications, such as mucositis, infection, or xerostomia, are common in patients with cancer receiving chemotherapy or radiotherapy. These complications can cause pain, leading to increased consumption of analgesics, poor... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Fertility Function Sequelae in Young Male Cancer Survivors
-
Yumura Y, Takeshima T, Komeya M, Karibe J, Kuroda S, Saito T
- KMID: 2540961
- World J Mens Health.
- 2023 Apr;41(2):255-271.
- doi: 10.5534/wjmh.220102
With advances in cancer treatment, such as cytotoxic chemotherapy and radiotherapy, grave new sequelae of treatment have emerged for young cancer survivors. One sequela that cannot be overlooked is male... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor Treatment
-
Jang YJ, Hyun Dg, Ji W, Choi CM, Yoon S, Lee DH, Kim SW, Lee JC
- KMID: 2541233
- Cancer Res Treat.
- 2023 Apr;55(2):468-478.
- doi: 10.4143/crt.2022.1342
Purpose We aimed to investigate the feasibility of four criteria on oligometastasis (OM) concerning clear survival benefits of local therapy (LT) during tyrosine kinase inhibitor (TKI) treatment in non–small cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Posttransplant sequential adrenal and spine metastasis of hepatocellular carcinoma responsive to combined regorafenib and radiotherapy: a case report
-
Kim JY, Yi NJ, Kim YJ, Chie EK, Kim J, Choi HH, Lee J, Lee S, Hong SY, Lee JM, Hong SK, Choi Y, Lee KW, Suh KS
- KMID: 2541315
- Korean J Transplant.
- 2023 Mar;37(1):69-75.
- doi: 10.4285/kjt.22.0054
Adrenal and spinal metastases of hepatocellular carcinoma (HCC) are rare entities with significant morbidity and mortality, particularly after liver transplantation (LT). We report a case of a 49-year-old man who... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Impact of Patient’s Head Position in Supraclavicular Irradiation of the Whole Breast Radiotherapy
-
Anbumani S, Reddy LG, V P, P S, Bilimagga RS
- KMID: 2541142
- Prog Med Phys.
- 2023 Mar;34(1):10-13.
- doi: 10.14316/pmp.2023.34.1.10
Patients with breast cancer can be positioned with their head turned to the contra lateral side or with their head straight during the radiation therapy treatment set-up. In our hospital,... -
- CITED
-
- Close
- SHARE
-
- Close
- Feasibility of a Linear Diode Array Detector for Commissioning of a Radiotherapy Planning System
-
Hong SM, Lee U, Kim Sw, Goh Y, Park MJ, Jeong C, Kwak J, Cho B
- KMID: 2541141
- Prog Med Phys.
- 2023 Mar;34(1):1-9.
- doi: 10.14316/pmp.2023.34.1.1
Purpose: Although ionization chambers are widely used to measure beam commissioning data, point-by-point measurements of all the profiles with various field size and depths are timeconsuming tasks. As an alternative,... -
- CITED
-
- Close
- SHARE
-
- Close
- Excluding prepontine cistern from whole ventricle radiotherapy target volume in localized germinoma
-
Ryu H, Lee JH
- KMID: 2540754
- Radiat Oncol J.
- 2023 Mar;41(1):48-57.
- doi: 10.3857/roj.2023.00031
Purpose: The target delineation of whole ventricle radiotherapy (WVRT) in germinoma varies among radiation oncologists, especially regarding the inclusion of the prepontine cistern (PC). We evaluated the outcome of PC-sparing... -
- CITED
-
- Close
- SHARE
-
- Close
- Liquid biopsy using cfDNA to predict radiation therapy response in solid tumors
-
Cho WK, Lee J, Youn SM, Oh D, Lim DH, Yoon HG, Cho EH, Noh JM
- KMID: 2540752
- Radiat Oncol J.
- 2023 Mar;41(1):32-39.
- doi: 10.3857/roj.2022.00444
Purpose: This study explored the potential feasibility of cell-free DNA (cfDNA) in monitoring treatment response through the measurement of chromosomal instabilities using I-scores in the context of radiation therapy (RT)... -
- CITED
-
- Close
- SHARE
-
- Close
- Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment
-
Jin S, Choi WM, Shim JH, Lee D, Kim KM, Lim YS, Lee HC, Jung J, Yoon SM, Choi J
- KMID: 2540830
- J Liver Cancer.
- 2023 Mar;23(1):177-188.
- doi: 10.17998/jlc.2023.03.04
Background/Aim: The Barcelona Clinic Liver Cancer (BCLC) guidelines recommend systemic therapy as the only first-line treatment for patients with BCLC stage C hepatocellular carcinoma (HCC) despite its heterogeneity of disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Low body mass index is associated with poor treatment outcome following radiotherapy in esophageal squamous cell carcinoma
-
Lee Jy, Choi Y
- KMID: 2540753
- Radiat Oncol J.
- 2023 Mar;41(1):40-47.
- doi: 10.3857/roj.2022.00640
Purpose: We aimed to determine whether patients with esophageal cancer with a low baseline body mass index (BMI) have a poor prognosis following radiotherapy (RT). Materials and Methods: We retrospectively analyzed... -
- CITED
-
- Close
- SHARE
-
- Close
- Favorable response of hepatocellular carcinoma with portal vein tumor thrombosis after radiotherapy combined with atezolizumab plus bevacizumab
-
Kim YT, Kim J, Seong J
- KMID: 2540836
- J Liver Cancer.
- 2023 Mar;23(1):225-229.
- doi: 10.17998/jlc.2023.02.27
Recently, the superiority of atezolizumab plus bevacizumab (AteBeva) over sorafenib was proven in the IMbrave150 trial, and AteBeva became the first-line systemic treatment for untreated, unresectable hepatocellular carcinoma (HCC). While... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases
-
Florez MA, De B, Chapman BV, Prayongrat A, Thomas JG, Beckham TH, Wang C, Yeboa DN, Bishop AJ, Briere T, Amini B, Li J, Tatsui CE, Rhines LD, Ghia AJ
- KMID: 2540750
- Radiat Oncol J.
- 2023 Mar;41(1):12-22.
- doi: 10.3857/roj.2022.00353
Purpose: There has been limited work assessing the use of re-irradiation (re-RT) for local failure following stereotactic spinal radiosurgery (SSRS). We reviewed our institutional experience of conventionally-fractionated external beam radiation... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of nearly complete response in hepatocellular carcinoma with disseminated lung metastasis by combination therapy of nivolumab and ipilimumab after treatment failure of atezolizumab plus bevacizumab
-
Kim HJ, Hwang SY, Im JW, Jeon KJ, Jeon W
- KMID: 2540834
- J Liver Cancer.
- 2023 Mar;23(1):213-218.
- doi: 10.17998/jlc.2023.02.23
Recently, the efficacy of immuno-oncologic agents for advanced hepatocellular carcinoma (HCC) has been proven in several trials. In particular, atezolizumab with bevacizumab (AteBeva), as a first-line therapy for advanced HCC,... -
- CITED
-
- Close
- SHARE
-
- Close
- Peripheral blood lymphocyte changes after stereotactic ablative body radiotherapy to lung or liver metastases in patients with oligometastatic cancers
-
Novikov SN, Baldueva IA, Zozulya AY, Emelyanova NV, Girdyuk DV, Arsenyev AI, Alexandrovna E, Tyuryaeva EI, Antipov EIFE, Girshovich MM, Kanayev SV
- KMID: 2540751
- Radiat Oncol J.
- 2023 Mar;41(1):23-31.
- doi: 10.3857/roj.2022.00521
Purpose: To perform the analysis of the peripheral blood lymphocyte changes after stereotactic ablative radiotherapy (SABR) in patients with oligometastatic cancers. Materials and Methods: The dynamics of the immune status in... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment
-
Cho Y, Kim BH, Kim TH, Koh YH, Park JW
- KMID: 2540833
- J Liver Cancer.
- 2023 Mar;23(1):206-212.
- doi: 10.17998/jlc.2023.02.09
Peritoneal seeding of hepatocellular carcinoma (HCC) is incurable and has poor prognosis. A 68-year-old man underwent surgical resection for a 3.5 cm single nodular HCC at the tip of segment... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer
-
Kim SH, Jo EJ, Mok J, Lee K, Kim KU, Park HK, Lee MK, Eom JS, Kim MH
- KMID: 2539974
- Korean J Intern Med.
- 2023 Mar;38(2):218-225.
- doi: 10.3904/kjim.2022.361
Background/Aims: Despite the obvious benefits of adding immune checkpoint inhibitors to platinum-etoposide chemotherapy in patients with extensive-stage small-cell lung cancer (ES-SCLC), real-world data remain scarce. Methods: This retrospective study included 89... -
- CITED
-
- Close
- SHARE
-
- Close
- Effects of Mesenchymal Stem Cells Treatment on Radiation-Induced Proctitis in Rats
-
Kim WH, Yoo JH, Yoo IK, Kwon CI, Hong SP
- KMID: 2539559
- Yonsei Med J.
- 2023 Mar;64(3):167-174.
- doi: 10.3349/ymj.2022.0342
Purpose: There are no effective treatment methods with which to control complications of radiation proctitis with fistula or recurrent bleeding following radiation treatment for prostate, cervical, or rectal cancer. Mesenchymal... -
- CITED
-
- Close
- SHARE
-
- Close
- Domestic medical travel from non-Seoul regions to Seoul for initial breast cancer treatment: a nationwide cohort study
-
Jeong JH, Jung J, Kim HJ, Lee JW, Ko BS, Son BH, Jung KH, Chung IY
- KMID: 2539221
- Ann Surg Treat Res.
- 2023 Feb;104(2):71-79.
- doi: 10.4174/astr.2023.104.2.71
Purpose: This study was conducted to investigate the trend of domestic medical travel from non-Seoul areas to Seoul for initial breast cancer treatment, and identify factors associated with medical travel... -
- CITED
-
- Close
- SHARE
-
- Close
- Role of Radiotherapy in Patients With Relapsed Medulloblastoma
-
Lim DH
- KMID: 2539326
- Brain Tumor Res Treat.
- 2023 Jan;11(1):22-27.
- doi: 10.14791/btrt.2022.0033
During the last three decades, the management of medulloblastoma (MBL) has made enormous progress with a multidisciplinary approach, incorporating surgery, radiotherapy (RT), and chemotherapy. Despite this improvement, 20%–30% of patients... -
- CITED
-
- Close
- SHARE
-
- Close
